SEC Form 4 insider trading filings tracked in real time from EDGAR

Farag Kameel D. — Interim CFO

Insider trading activity for Farag Kameel D. sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Interim CFO
  • Company: Akari Therapeutics Plc
  • Total insider trades: 7
  • Total buy volume: $105K
  • Total sell volume: $0
  • Last trade: Jun 25, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 1,000 $13K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 7,353 $28K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 3,725 $13K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 2,539 $13K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 1,570 $13K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 1,395 $13K
Jun 24, 2026 Farag Kameel D. AKTX Akari Therapeutics Plc BUY 1,248 $13K

← All executives · Full trades feed